Wheeler Bio

company

About

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$14M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, biomanufacturing and portable CMC platform.

Wheeler Bio was established in 2020 by Jesse McCool in Oklahoma City.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$14M
Wheeler Bio has raised a total of $14M in funding over 2 rounds. Their latest funding was raised on Oct 4, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 4, 2022 Series A 1 Detail
Jan 4, 2022 Seed $14M 1 Alloy Therapeutics Detail
Jul 21, 2021 Funding Round 1 Alloy Therapeutics Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Wheeler Bio is funded by 2 investors. Alloy Therapeutics and Pine Ridge Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Alloy Therapeutics Yes Seed
Pine Ridge Ventures Series A